Page last updated: 2024-08-24
sesamol and Neurodegenerative Diseases
sesamol has been researched along with Neurodegenerative Diseases in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Gao, JM; Li, L; Liu, Q; Liu, X; Liu, Z; Mo, F; Xi, Y; Xie, T; Yuan, T | 1 |
Chen, W; Dai, X; Guo, R; Jia, M; Liu, X; Liu, Z; Wang, Y; Xie, T; Yang, C; Yuan, T; Yun, D; Zhang, Y; Zhao, Y | 1 |
Other Studies
2 other study(ies) available for sesamol and Neurodegenerative Diseases
Article | Year |
---|---|
Sesamol Attenuates Amyloid Peptide Accumulation and Cognitive Deficits in APP/PS1 Mice: The Mediating Role of the Gut-Brain Axis.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzodioxoles; Brain; Cognition; Cognitive Dysfunction; Disease Models, Animal; Mice; Mice, Transgenic; Neurodegenerative Diseases; Peptides; Phenols | 2021 |
Sesamol Attenuates Scopolamine-Induced Cholinergic Disorders, Neuroinflammation, and Cognitive Deficits in Mice.
Topics: Animals; Antioxidants; Cholinergic Agents; Cognition; Cognitive Dysfunction; Humans; Lignans; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Nerve Growth Factors; Neuroblastoma; Neurodegenerative Diseases; Neuroinflammatory Diseases; Neuroprotective Agents; Oxidative Stress; Scopolamine; Sesame Oil | 2022 |